(Q39379523)

11 September 2017

1 reference

title

Rheumatoid arthritis and connective tissue disorders: sub-Saharan Africa (English)

1 reference

11 September 2017

0 references

1 reference

1 reference

Mody GM

1

1 reference

11 September 2017

language of work or name

1 reference

1 February 1995

1 reference

Bailliere's clinical rheumatology

11 September 2017

published in

1 reference

11 September 2017

volume

9

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

31-44

1 reference

Rheumatoid arthritis: a twentieth century disease in Africa?

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Serological profile of rheumatoid arthritis in west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in Kenya. I. Clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Polymyositis: report on three cases from West Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in a rural South African Negro population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Outcome and survival in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Silica-dust-exposed mine workers with scleroderma (systemic sclerosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Serological profiles in the connective tissue diseases in Zimbabwean patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Tuberculosis in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Anglo-French contributions to the recognition of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Autoimmune disease and parasitic infections in Nigerians

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Polyarthritis in Western Nigeria. I. Rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Low Incidence of Rheumatoid Factor and Autoantibodies in Nigerian Patients with Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Interaction between Entamoeba histolytica and Human Polymorphonuclear Neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

RHEUMATOID ARTHRITIS IN LIBERIA, WITH AN ASSESSMENT OF SEROLOGICAL FINDINGS.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Adult and juvenile rheumatoid arthritis: current epidemiologic concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in Ugandan Africans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Chronic inflammatory rheumatic diseases in black Zimbabweans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

The association between HLA and rheumatoid arthritis in Zimbabwean blacks

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in a tribal Xhosa population in the Transkei, Southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

A radiographic survey of hip involvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in blacks in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in Lesotho

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

A population study on rheumatoid arthritis in Lesotho, southern Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Antiglobulins in Nigerians with rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

HLA-D region heterogeneity in a Nigerian population.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

HLA-DR antigens and rheumatoid arthritis in black South Africans: A study of ethc groups

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Systemic lupus erythematosus and renal involvement. A South African experience

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

The antiquity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatoid arthritis in an urban South African Negro population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Rheumatic disorders in Zimbabwe: a prospective analysis of patients attending a rheumatic diseases clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Photosensitivity and anti-Ro (SS-A) antibodies in black patients with systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Systemic lupus erythematosus in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

Assessment of Radiological Changes in the Hands and Feet in Rheumatoid Arthritis. Their Correlation with Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980141-4

7 January 2021

10.1016/S0950-3579(05)80141-4

Identifiers

DOI

1 reference

11 September 2017

1 reference